PDCD1 and neoplasm: This is largely because the interaction between checkpoint molecule programmed cell death protein 1 (PD-1) on T cells and its ligands PD-L1/2 expressed on tumor cells inhibits T cell activation, inducing immune escape and significantly decreasing the efficacy of immunotherapy (3).